| Revenue growth | 9.13% YoY consolidated growth. |
|---|---|
| Margins | EBITDA margins moderated to 12.51% due to expansion costs. |
| Demand visibility | Strong; 13.1% India IVF CAGR expected through 2034. |
| Management confidence | High; expanding network to 10 hubs in FY27-28. |
Growth
Consolidated revenue grew 9% YoY. Standalone EBITDA and PAT declined 48% and 29% respectively due to aggressive expansion spending.
Outlook
Targeting 10 new hubs by FY28, with two launching soon in Delhi/NCR and Nagpur to drive scale.
Risks
Front-loading of pre-operational expenses and hiring costs led to significant margin compression in the current quarter.
Investor Presentation filed with BSE, NSE: GAUDIUMIVF. Summary written with AI assistance from the document.
Gaudium IVF And Women Health Ltd: key numbers
- Share price
- ₹109.28
- Market cap
- ₹795.4 Cr
- Revenue (annual)
- ₹104.4 Cr
- Net profit (annual)
- ₹24.46 Cr
- P/E (TTM)
- 34.4×Sector 40.4×
- Promoter holding
- 71.29%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gaudium IVF And Women Health Ltd
All →Gaudium IVF And Women Health Capacity Expansion
Gaudium IVF and Women Health Limited commenced operations at its new IVF Centre/Hub in Gurgaon, Haryana, effective September 24, 2026.
- new IVF center
- 1.0 centers
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Limited has intimated the exchange about sending physical letters to shareholders for accessing the Annual Report for FY 2025-26.
Gaudium IVF And Women Health Annual Report
Gaudium IVF and Women Health Limited submitted its Annual Report for the Financial Year 2025-26. The 11th Annual General Meeting is scheduled for September 28, 2026.
Gaudium IVF And Women Health Annual General Meeting
Gaudium IVF and Women Health Limited will hold its 11th AGM on September 28, 2026. The meeting will be conducted via Video Conferencing to consider several resolutions.
Gaudium IVF And Women Health Management Change
Gaudium IVF and Women Health Limited has re-appointed Ram Rattan & Associates as Internal Auditor for a 12-month term.
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Limited has re-appointed Ram Rattan & Associates as the Internal Auditor for a 12-month term.
- Execution
- 12 months